The Netherlands is home to 2,900 innovative Life Sciences businesses, including 420 biopharmaceutical companies, and the European Medicines Agency, making it one of the most concentrated Life Sciences and Health clusters in the world. About 770 clinical trials are currently active in the Netherlands and the country boasts a competitive international business climate which is reflected by its status as the sixth-largest EY economy, a major global exporter and importer of goods and a Forbes ranking as the third best country for doing business. Together with a very strong scientific background it makes the Dutch industry a major European player with great economic- and societal impact. The Dutch Life Sciences conference is hosted by organisations and companies whose mission is to help realize the further development and growth of the Dutch life sciences industry.
The 15th edition of the Dutch Life Sciences conference will take place at the Leiden Bio Science Park on November 28th, 2019. The conference inspires and promote an open exchange of information including trends and developments in the industry.
During the conference, the winner of the Venture Challenge Fall 2019 will be announced. The Venture Challenge is part of the LifeSciences@work programme, a coherent support programme for all Life Sciences starters. The programme further consists of plenary sessions and parallel sessions, an investors forum, active networking possibilities and an information market.
The first announced keynote speaker is astronaut Dr. André Kuipers. He offers a unique look behind the scenes of international human spaceflight. He shares his story about the training, the mission and the medical aspects of being on board of the ISS.